Abstract
Tumor immune tolerance plays a critical role in tumor cell survival; the establishment of tumor immune tolerance is incompletely understood yet. Integrin alphavbeta6 (avb6) is involved in tumor growth and metastasis. This study aimed to observe the effect of avb6 on the development of tumor tolerance in colorectal cancer (CRC). In this study, 28 CRC patients were recruited. The frequencies of tolerogenic dendritic cells (TolDC), regulatory T cells (Treg), and CD8+ T cells in surgically removed CRC tissue were assessed by flow cytometry. The levels of avb6 in CRC tissue were measured by enzyme-linked immunoassay (ELISA). The effect of avb6 on inducing TolDCs and Tregs was evaluated with the cell culture model. The results showed that in surgically removed CRC tissue, we detected higher frequencies of TolDC and Tregs, lower frequency CD8+ T cells and high levels of avb6 as compared with non-CRC tissue. CRC protein extracts could induce TolDC development that could be blocked by anti-avb6 antibody. CRC-derived DCs could convert naïve CD4+ T cells to Tregs. Peripheral CD8+ T cells from CRC patients still retained the ability to produce granzyme B and to proliferate in response to CRC tumor antigen in culture that was abolished by the presence of CRC-derived Tregs. We conclude that CRC-derived avb6 is involved in the establishment of tumor immune tolerance in local tissues.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Nosho K, Baba Y, Tanaka N, Shima K, Hayashi M, Meyerhardt JA et al (2010) Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol 222:350–366
Wang HY, Wang RF (2007) Regulatory T cells and cancer. Curr Opin Immunol 19:217–223
Flavell RA, Sanjabi S, Wrzesinski SH, Licona-Limon P (2010) The polarization of immune cells in the tumour environment by TGFbeta. Nat Rev Immunol 10:554–567
Pinchuk IV, Beswick EJ, Saada JI, Boya G, Schmitt D, Raju GS et al (2011) Human colonic myofibroblasts promote expansion of CD4+ CD25 high Foxp3+ regulatory T cells. Gastroenterology 140:2019–2030
Coombes JL, Siddiqui KRR, Arancibia-Caírcamo CV, Hall J, Sun CM, Belkaid Y et al (2007) A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta- and retinoic acid-dependent mechanism. J Exp Med 204:1757–1764
Morris DG, Huang X, Kaminski N, Wang Y, Shapiro SD, Dolganov G et al (2003) Loss of integrin [alpha]v[beta]6-mediated TGF-[beta] activation causes Mmp12-dependent emphysema. Nature 422:169–173
Saha A, Ellison D, Thomas GJ, Vallath S, Mather SJ, Hart IR et al (2010) High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6. J Pathol 222:52–63
Salagianni M, Lekka E, Moustaki A, Iliopoulou EG, Baxevanis CN, Papamichail M et al (2011) NK cell adoptive transfer combined with ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses. J Immunol 186:3327–3335
Augier S, Ciucci T, Luci C, Carle GF, Blin-Wakkach C, Wakkach A (2010) Inflammatory blood monocytes contribute to tumor development and represent a privileged target to improve host immunosurveillance. J Immunol 185:7165–7173
Zou W (2006) Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 6:295–307
Yang GY, Xu KS, Pan ZQ, Zhang ZY, Mi YT, Wang JS et al (2008) Integrin alphavbeta6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver. Cancer Sci 99:879–887
Ghannad F, Nica D, Garcia Fulle MI, Grenier D, Putnins EE, Johnston S et al (2008) Absence of [alpha]v[beta]6 integrin is linked to initiation and progression of periodontal disease. Am J Pathol 172:1271–1286
Matta BM, Castellaneta A, Thomson AW (2010) Tolerogenic plasmacytoid DC. Eur J Immunol 40:2667–2676
Fontana L, Chen Y, Prijatelj P, Sakai T, Fassler R, Sakai LY et al (2005) Fibronectin is required for integrin alphavbeta6-mediated activation of latent TGF-beta complexes containing LTBP-1. FASEB J 19:1798–1808
Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity: roles in cancer suppression and promotion. Science 331:1565–1570
Ribas A (2010) Clinical development of the anti-CTLA-4 antibody tremelimumab. Semin Oncol 37:450–454
Campbell DJ, Koch MA (2011) Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 11:119–130
Salama P, Phillips M, Grieu F, Morris M, Zeps N, Joseph D et al (2009) Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27:186–192
Antony PA (2002) Do CD4+ CD25+ immunoregulatory T cells hinder tumor immunotherapy? J Immunother 25:202–206
Curtin JF (2008) Treg depletion inhibits efficacy of cancer immunotherapy: implications for clinical trials. PLoS One 3:e1983
Taylor AW (2009) Review of the activation of TGF-beta in immunity. J leuko Biol 85:29–33
Katsura Y, Suzukawa K, Kojima H, Yoshida C, Shimizu S, Mukai H et al (2003) Cytotoxic T-cell lymphoma arising in Behcet disease. Int J Hematol 77:282–285
Acknowledgments
This study was supported by grants from the Canadian Institutes of Health Research (#191063, #177843) and Beijing Scientific Foundation.
Conflict of interest
None to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
S.-B. Yang and Y. Du were equally contributed to this work.
Rights and permissions
About this article
Cite this article
Yang, SB., Du, Y., Wu, BY. et al. Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer. Cancer Immunol Immunother 61, 335–342 (2012). https://doi.org/10.1007/s00262-011-1108-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00262-011-1108-1